Source:http://linkedlifedata.com/resource/pubmed/id/15710208
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-2-15
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0168-8278
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
290-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15710208-Anti-HIV Agents,
pubmed-meshheading:15710208-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15710208-Antiviral Agents,
pubmed-meshheading:15710208-HIV Infections,
pubmed-meshheading:15710208-Hepatitis C,
pubmed-meshheading:15710208-Humans,
pubmed-meshheading:15710208-Risk Assessment
|
pubmed:year |
2005
|
pubmed:articleTitle |
Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
|
pubmed:publicationType |
Editorial,
Comment,
Research Support, Non-U.S. Gov't
|